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ABSTRACT
Antimicrobial peptides (AMPs) are regarded as promising alternatives for 
antibiotics due to their inherent capacity to prevent microbial drug resistance. 
Amphibians are rich source of bioactive molecules, which provide numerous AMPs 
with various structures as drug candidates. Here, we isolated and identified a novel 
AMP Brevinin-2Ta (B-2Ta) from the skin secretion of the European frog, Pelophylax 
kl. esculentus. In vitro studies revealed that it showed broad antimicrobial activities 
against S. aureus, E. coli and C. albicans with low cytotoxicity to erythrocytes. 
Furthermore, we examined the anti-inflammation effect in vivo by using Klebsiella 
pneumoniae-infected Sprague-Dawley (SD) rats. The wound closure outcomes 
revealed that B-2Ta effectively restrained the bacterial infection at a dose of 10 
times minimal inhibitory concentration (MIC) during the 14 days of the wound healing 
process. Ultra-structure analyses showed that B-2Ta caused structural damage to 
the microorganism, and bacterial culture found that the number of microbes was 
significantly reduced by the end of treatment. Immunohistochemistry for the 
inflammatory marker IL-10 and the endothelial cell marker CD31 suggested positive 
effects on inflammatory status and epithelial migration and angiogenesis following 
treatment of the infected granulation tissues with B-2Ta. These results exhibited 
the continuous phase of inflammation reduction and wound healing acceleration 
in the B-2Ta-modulated re-epithelialisation of K. pneumoniae infected rats. Taken 
together, these data demonstrated that B-2Ta has great potential to be developed as 
antibacterial agents in clinic.
INTRODUCTION
Bacterial infections occur with injuries, acute or 
chronic ulcers or after surgical treatment. Pathogenic 
organisms can invade the whole body, attach to cells 
and multiply in the host, and in some cases, the immune 
system fails to prevent the infections caused by these 
pathogens. Bacteria exist on the surface of the skin and 
infections are commonly initiated following injuries or 
immunity depression. Skin wounds are immediate causes 
which lead the microorganisms to break through the 
skin into the circulatory system and usually occur with 
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trauma and ulcers, for example, diabetic foot gangrene, 
which is commonly infected by the Gram-positive bacteria 
Staphylococcus aureus, β-haemolytic streptococci and the 
Gram-negative Klebsiella pneumonia (K. p).
K. p is one of the most common pathogens in 
nosocomial infections, and it has become increasingly 
multidrug-resistant. It causes serious pulmonary and 
urinary tract infections in hospitalised patients, patients 
with diabetes, alcoholism, and chronic lung disease 
are also susceptible for Klebsiella [1]. Large numbers 
of clinical cases with chronic ulcers are reported to be 
infected by multiple microbes including K. p. Point 
mutations and resistance genes acquisition through 
lateral gene transfer are two major causes that lead to the 
development of multi-drug resistant K. p [2]. Multi-faceted 
factors are involved in K. p infections in a coordinated 
manner [3].
When bacteria invade the internal environment 
through dermal injuries, proliferation and reproduction 
of bacterial factors occur first, then the inflammatory 
response is induced and followed by the immune response. 
The wound healing process is divided into 4 phases: 
homeostasis, inflammation, granulation (proliferation) and 
remodelling. During periods of rebuilding extracellular 
matrix, fibroplasia and angiogenesis, significant molecular 
networks, such as adhesion molecules, proteinases, 
cytokines, chemokines and growth factors, are involved 
[4]. Endogenous microbes can infect the surgical wounds 
from the organs inside the body or exogenous microbes 
on the skin/in the air, in particular for diabetic patients 
who are taking corticosteroids or who just had surgery. 
The general treatment for wound infections is antibiotics 
and surgery. In such cases, selective and effective 
antibiotic alternatives, especially those with the potential 
to overcome drug resistance, are a valuable therapeutic 
option.
In this study, a novel AMP named B-2Ta was 
isolated and identified from the European frog Pelophylax 
kl. esculentus, it showed broad spectrum antimicrobial 
properties and anti-proliferative effects against several 
bacterial strains with low toxicity. In a pre-clinical in 
vivo study, B-2Ta effectively inhibited the inflammatory 
responses and promoted angiogenesis in SD rats. 
Therefore, we report that B-2Ta is a potential therapeutic 
agent for effectively promoting K. p-infected wound 
healing.
RESULTS
Molecular cloning of B-2Ta precursor cDNA 
from pelophylax kl. esculentus skin secretion
The B-2Ta precursor encoding cDNA was 
repeatedly cloned and replicated by RACE PCR 
procedures from the skin secretion derived cDNA library. 
The open reading frame of this cDNA consisted of 74 
amino acid residues, of which the first 22 residues were a 
putative signal peptide domain, a two-amino acid (-Lys40-
Arg41-) propeptide convertase processing motif that is 
responsible for enzyme digestion [5], and a single copy 
of a 33-amino acid residue mature peptide (GILDTLK
NLAKTAGKGILKSLVNTASCKLSGQC) was located 
at the C-terminal (Supplementary Figure 1). BLAST 
results indicated that a single residue substitution existed 
between the homologous precursor sequences from 
Rana. temporaria and Pelophylax kl. esculentus. Also, 
the novel B-2Ta isolated from Pelophylax kl. esculentus 
shared 85% identity with five others mature brevinin-2 
peptides isolated from three congeneric species which 
were Pelophylax ridibundus (brevinin-2Eg, accession 
no. P86154; brevinin-2Ef, accession no. P86153), 
Pelophylax kl. esculentus (brevinin-2E, accession no. 
P32413), and Rana temporaria (brevinin-2Tb, accession 
no. P82269) (Figure 1). Analyses of cDNAs coding for 
the corresponding precursors indicated that a single 
copy of the mature peptide sequence was preceded by a 
dibasic cleavage site and followed by a stop codon [6]. 
The nucleotide sequence of the cDNA encoding the novel 
antimicrobial Brevinin-2Ta peptide precursor from the 
skin secretion of Pelophylax kl. esculentus, has been 
Figure 1: Alignment of B-2Ta with its closest homologues identified via BLAST analyses of the NCBI database. The 
conserved regions are highlighted in black; grey areas indicate the less conserved residues, sites of amino acid which have remarkable 
differences are shown in the blank. Database accession numbers are listed following each named homologue.
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deposited in the EMBL Nucleotide Sequence Database 
under the accession code: LT615139.
Isolation and structural characterisation of 
B-2Ta
The putative mature peptide B-2Ta was identified in 
a fraction generated by reverse phase HPLC (rp-HPLC) of 
Pelophylax kl. esculentus skin secretion (Supplementary 
Figure 2). MALDI-TOF mass spectrometry, using a 
Perseptive Biosystems Voyager DE system in linear mode, 
identified this single peptide with an m/z of 3347.01(data 
not shown). Electrospray ion-trap MS/MS established the 
primary structure of the peptide B-2Ta as: GILDTLKN
LAKTAGKGILKSLVNTASCKLSGQC (Supplementary 
Figure 3). Previous studies reported that peptides 
belonging to this family possess an intramolecular 
disulphide bridge at the C-terminus [6]. The unequivocally 
establishment of the primary structure of mature B-2Ta 
was achieved using LCQ fleet™ electrospray ion-trap 
mass spectrometry and molecular cloning strategy. 
Solid Phase Peptide Synthesis was employed to obtain 
peptide replicates for functional testing. The MALDI-
TOF was used for the purity assessment of the synthetic 
peptide, which constituted >90% of the total components. 
Secondary structure, predicted using the SWISS-
MODEL database (Figure 2A), indicated that the α-helix 
occupied the main part of B-2Ta, while two cysteines of 
the nonapeptide tail at the C-terminal, created a cyclic 
structure by a disulphide bridge. The helical wheel plots 
are shown in Figure 2B. The aggregated distribution 
of cationic and hydrophobic residues on the opposite 
surfaces of the helix forms an amphipathic structure 
which confirmed the potential of the peptide to interact 
with cellular membrane structures. The 3D mimic pattern 
(Figure 2C) visualised the structural mode of B-2Ta which 
consisted of two separate parts of a helical unit connected 
to a random amino acid chain.
Evaluation of antimicrobial and haemolytic 
effects of B-2Ta
The data obtained from minimal inhibitory 
concentration (MIC) and minimal bactericidal 
concentration (MBC) assays on the synthetic peptide 
B-2Ta were compared to those of melittin and ampicillin 
[7] (Table 1). MICs of B-2Ta were 64 mg/L (20 μM) 
against S. aureus, 32 mg/L (10 μM) against E. coli, and 
64 mg/L (20 μM) against C. albicans. As a well-defined 
broad-spectrum antibacterial honey bee venom peptide, 
melittin possessed distinct cytotoxicity (>70% haemolysis) 
at the MICs. Ampicillin exhibited strong effects against S. 
aureus (0.0625 mg/L) and E. coli (0.125 mg/L), whereas 
it was ineffective towards C. albicans. The MBCs of the 
natural peptides, B-2Ta and melittin, were found to be 
two-fold higher compared with their MICs. However, 
MBCs of ampicillin against S. aureus and E. coli were 
256 and 64-fold increase over the MICs, respectively. 
The haemolytic effect of B-2Ta are shown in Figure 3B, 
it displayed that 60% of horse blood erythrocytes were 
lysed at the maximal concentration of peptide (512 mg/L), 
while the peptide possessed only low level of haemolysis 
(<10%) at the MICs against S. aureus, E. coli and C. 
albicans (Table 1).
Meanwhile, the antimicrobial assessment of B-2Ta 
against K. pneumoniae in vitro showed that the MIC value 
was 64 mg/L, and IC50 value was 38.1 mg/L (Figure 3A).
B-2Ta improves K. pneumoniae-infected wound 
healing in SD rats
Wound closure assessment was based on the areas 
of the last generated tissues covering the dermal wounds. 
Figure 4A shows the fresh impaired wound of a SD rat 
and the healing degree on days 1, 4, 9 and 13. Rats in the 
uninfected control group appeared to be slightly purulent 
on the wound surface at day 4, which was normal during 
the inflammation phase. Other infected groups exhibited 
a slight bleeding thick mixture of layers of organisms 
and purulence. Statistical analyses showed that K. p–
infected rats regenerated 5% less tissues than the other 
groups in the first four days (Figure 4B). During the 
proliferation and maturation phases, the granular tissues 
that contained collagen and extracellular matrix, were 
rebuilt and angiogenesis developed. At day 9, the K. 
p–infected group (group B) appeared to develop severe 
inflammation, and wound healing was barely observed. 
10×MIC B-2Ta-treated group (group D) showed a mass 
of maturation and dark coloured granulation, suggesting a 
rebuilt and angiogenesis process. The 2×MIC gentamicin-
treated group (group C) presented pinker granular tissues 
and less inflammatory purulence. On the 13th day, all 
the wounds began to scab with thinner moist areas and 
less inflammation except the K. p–infected group (group 
B), where the 10×MIC B-2Ta-treated group (group D) 
displayed comparable wound heal rate (55.4%) with 
2×MIC gentamicin-treated group (group C) (56.7%), 
while the uninfected group (group A) exhibited a slightly 
lower heal rate (48.8%). The morphological measurement 
showed the notable improvement of 10×MIC B-2Ta-
treated rats during the period of re-epithelialisation 
compared with the non-interventional control (group B), 
which was at the same level compared with conventional 
antibiotics. Supplementary Table 2 summarises the marks 
of scores for the general morphological features of each 
group during the experimental period.
B-2Ta decreases K. pneumoniae counts in wound 
area
B-2Ta and gentamicin exhibited MICs of 64 
mg/L and 32 mg/L against K. p respectively. To assess 
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the wound healing efficiency, the quantity of bacteria 
was determined as colony forming units / gram tissue 
(CFU/g). Figure 5 showed that the number of bacteria in 
all infected groups (group B, C, D) were all at the same 
level (7.95×108± 2.30×108 CFU/g) after inoculation (day 
1). After the treatment of 2×MIC gentamicin and 10×MIC 
B-2Ta for 13 days, a significant reduction was observed in 
2×MIC gentamicin-treated group with 1.85×104±0.35×104 
CFU/g and in 10×MIC B-2Ta-treated group with 
1.88×104±0.73×104 CFU/g. The bacterial culture screening 
of the exudate samples from wound areas at different time 
points reflected the same declining trend of the numbers 
of colonies (Supplementary Figure 3). Specifically, 
the data showed that the numbers of bacterial colonies 
were maintained at a high level on day 4 except for the 
uninfected group, while the microbial proliferation of 
2×MIC gentamicin and 10×MIC B-2Ta treated groups 
became sparser on day 9, and prominent decline appeared 
on day 13.
Figure 2: The spatial characteristics of the peptide simulated in three aspects, (A) SWISS-MODEL assessment of secondary structure of 
the mature peptide B-2Ta. C=random coils and H=helix. (B) Helical wheel plot of B-2Ta, indicates its amphipathic properties, the residues 
L9, I2, L6, I17, L3, L21 occupied one side of the helix and the cationic amino groups K7, K11, K15, K19 presented on the other side. (C) 
The 3D model graph of B-2Ta predicted via the SWISS-MODEL ExPASY server and visualised by the PyMOL platform. Random chains 
connected two modules of the helical column.
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Meanwhile, the morphology changes of bacteria 
were observed by using scanning electron microscopy 
(SEM). The graphs in Figure 6 showed that the normal 
bacteria were rod-shaped, with integrated fimbriae around 
the enclosures. When treated with B-2Ta (10×MIC=0.64 
mg/ml) or gentamicin (2×MIC=64 mg/L), bacterial 
membranes were disrupted, causing the pore formation 
and the breakdown of structural integrity.
B-2Ta improves the skin re-epithelisation, 
granulation and collagen deposition in wound 
area
Figure 7 displayed the haematoxylin and eosin 
(H&E) stained sections of granulation/healing tissue from 
different groups with or without treatment of gentamicin 
or B-2Ta. The uninfected control (group A) showed less 
inflammatory cell migration and integrated epithelial 
layer. The K. p-infected control (group B) showed a 
typical infection process with thin granulated tissue, sparse 
fibroblasts, and thick inflammatory cells. Meanwhile, the 
vessels are shapeless. Compared with the control groups, 
the 2×MIC gentamicin-treated group (group C) has 
improved healing process with regular epithelial layers 
and abundant integrated vessel circles presented, also, the 
fibroblast and collagens are clear in the wound sections. 
The inflammation status reflected that the 10×MIC 
B-2Ta-treated wounds (group D) contained more smooth 
collagens and fibroblasts compared with the infected 
control, and the regular epithelial layers and integrated 
vessel circles has been improved.
B-2Ta enhances epithelial migration and 
angiogenesis
Photomicrographs in Figure 8 A showed the CD31 
expression in tissues with wound edge and the distribution 
of blood capillaries on day 9. The arrows indicated that 
the capillaries were present as cyclic sections, according 
to which, we can regard the regular and integrated circular 
rings as positive microvessels, which are normally 
constituted by 3-4 cells (with a visualised nucleus) 
and associated with CD31 accumulation, the positive 
vessels represented an epithelial regeneration status. In 
Figure 8A, the K. p-infected control group (group B) 
appeared to have incomplete edges with few and irregular 
capillary sections, which was relatively poor re-epithelial 
conditions; the uninfected control group (group A) 
Table 2: Treatment of groups A, B, C and D according to the in vitro MIC assay
Groups Conditions No. Wound Infection Reagents Treatment
A Untreated control 1-8 √ × Normal saline 500 mL Clean purulent exudate
B Infection control 9-16 √ √ Normal saline 500 mL Add reagent
C 2×MIC gentamicin 17-24 √ √ Gentamicin (2×MIC 500 mL) Change the dressing
D 10×MIC B-2Ta 25-32 √ √ B-2Ta (10×MIC 500 mL)  
Note: The MIC values of gentamicin and B-2Ta were 32 mg/L and 64 mg/L against K. p, the inoculation concentration of 
group C and group D were 64 mg/L and 0.64 mg/ml, respectively.
Table 1: Mean MICs and MBCs of the B-2Ta, melittin and ampicillin against the S. aureus, E. coli and C. albicans
 S. aureus E. coli C. albicans
  MICs (mg/L & μM) and haemolysis (%) at corresponding MIC values 
B-2Ta 64 mg/L (20 μM) (9%) 32 mg/L (10 μM) (3%) 64 mg/L (20 μM) (9%)
Melittin 8 mg/L (2.8 μM) (73.8%) 16 mg/L (5.6 μM) (75.2%) 8 mg/l (2.8 μM) (73.8%)
Ampicillin 0.0625 mg/L (0.18μM) (0%) 0.125 mg/L(0.36μM) (0%) NE
  MBCs (mg/L &μM)  
B-2Ta 128 mg/L (40 μM) (15%) 64 mg/L (20 μM) (9%) 128 mg/L (40 μM) (15%)
Melittin 16 mg/L (5.6μM) 32 mg/L (11.2μM) 16 mg/L (5.6μM)
Ampicillin 16 mg/L (45.8μM) 8 mg/L (22.9μM) NE
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contained well-shaped vessels and higher density of CD31 
staining, indicating active angiogenesis in its proliferation 
phases; the 2×MIC gentamicin-treated group and 10×MIC 
B-2Ta-treated group (group C, D) started to heal in a 
middle degree compared with the control groups, which 
presented well-shaped vessels and slightly lower expressed 
CD31 levels than the uninfected control (group A) before 
Day 13 (Figure 8C). IL-10 is a product of inflammatory 
responses and it is a component of an activity-dependent 
negative-feedback loop, which plays a significant role in 
inflammation control [8]. Expression of IL-10 in the re-
epithelial wound tissue has a close correlation with the 
inflammation degree. Photomicrographs in Figure 8B 
presented the situations of IL-10 expression in the tissues 
of day 9. Apparently, the K. p-infected group (group 
B) expressed deepest yellow stains, indicating a large 
quantity of activated IL-10. In contrast, the uninfected 
group and the infected groups treated with antibiotics and 
Figure 3: (A) Antimicrobial activity of B-2Ta against K. p. The MIC value was 64 mg/L, IC50=38.1 mg/L. (B) Haemolytic activity 
of B-2Ta. The maximal concentration caused 60% red cells lysis, while this activity significantly decreased to less than 10% at MICs of 
B-2Ta towards each organism.
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B-2Ta displayed lighter stain. The trend was displayed in 
statistical analysis (Figure 8 D). The K. p-infected control 
group (group B) indicated a highest expression of IL-
10 during the whole process, which was approximately 
twice higher than other groups at Day 9 and Day 13. The 
10×MIC B-2Ta-treated group (group D) expressed less IL-
10 on Day 9 than 2×MIC gentamicin-treated group (group 
C), and displayed an equal level expression of IL-10 and 
Figure 4: B-2Ta improved K. p-infected wound healing. (A) The morphological changes in wound area of uninfected, 108 K. p-
infected, 2×MIC gentamicin-treated and 10×MIC B-2Ta-treated groups at 1, 4, 9, 13 days. (B) The re-built wound areas of four experimental 
groups, which were calculated by normalised with initial wounding area on day 0. Data were compared using ANOVA (Bonferroni test) 
with the SPSS statistical software 18.0. Significance: ****P<0.0001 vs K. p-infected group, ***P<0.001 vs K. p-infected group, **P<0.005 vs 
K. p-infected group.
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Figure 5: Quantitative bacterial culture of excised tissues on day 1, 4, 9, 13 after infection. Significance: ## or **P<0.01 vs 
K. p-infected group.
Figure 6: SEM micrographs of infected control (a, b), 2×MIC gentamicin-treated (c) and 10×MIC B-2Ta-treated samples of clinical K. 
p. (a, b) The bacteria presented as rod-shaped, with integrated fimbriae around the enclosures. (c, d) The treatment of 2×MIC gentamicin or 
10×MIC B-2Ta led to rapid transmembrane pore formation close to the polar and septal regions and breakdown of the integrity of bacterial 
surfaces.
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on Day 13, which represented that the 10×MIC B-2Ta 
exhibited an even better performance in neutralising the 
inflammation of K. p than 2×MIC gentamicin.
DISCUSSION
Wound healing is a synergistic process, which 
involves various cells, cytokines and growth factors of 
the internal environment, while external factors can also 
affect the healing process. There are three indicators of 
inflammatory response: inflammatory inducers (infection 
or tissue damage), inflammatory sensors (mast cells and 
macrophages), and inflammatory mediators (cytokines 
and chemokines) [9]. The open dermal wounds are 
susceptible to the aerobic bacteria which can cause 
infections in the outer layers of skin, the infections could 
extend into subcutaneous layer, and subsequently alter 
the wound microenvironment and impair epithelialisation 
of the wound. Some clinical bacteria usually acquire 
additional mutations to resist the effects of conventional 
antimicrobial agents. Additionally, the microorganisms 
could also survive in the biofilm in wounds, in this case, 
practical therapeutic approaches are required, even if 
the mechanisms of infection are controversial [10]. In 
this in vivo study, we employed a model which debrides 
the biofilm and retains the infected granular tissue on 
the rats, and we treated the wound by using a novel 
identified B-2Ta peptide to assess the efficiencies of this 
antimicrobial agent.
B-2Ta is a short antimicrobial peptide which 
contains a cysteine disulphide bond whose specific 
amphipathic alpha-helix structure is currently perceived 
as being involved in interaction with the well-defined 
lipid bilayers of bacterial outer membranes. The current 
proposed theories about how AMPs lead to microorganism 
damage are ‘barrel-stave’, ‘carpet’ and ‘toroidal-pore’ 
modes, which may facilitate the formation of pores 
and lysis of the bacterial cellular outer membranes. In 
this study, we performed 10×MIC B-2Ta concentration 
administration, which aimed to minimise the differences 
of the efficacy between animals, and enhance the killing 
efficiency of the peptide [11, 12]. The SEM photographs 
showed the regular shaped holes on the K. p cell 
membranes when treated with a high-dosage of B-2Ta, 
confirming the structural deficiency on bacteria caused 
by AMP in vivo. The bacteria and bacteria-free serum 
are collected from the animal rather than lab-conserved 
materials to maintain the authenticity and consistency of 
the experimental design. In consideration of many impact 
factors, which can influence the treatment efficiency, 
Figure 7: H&E stained histopathological sections of granulation/healing tissues. The tissues were from (a) uninfected control, 
(b) 108 K. p-infected group, (c) 2×MIC gentamicin-treated group, and (d) 10×MIC B-2Ta-treated group, collected on day 9 after infection. 
I: inflammation, F: fibroblasts, C: collagen, E: epithelial layer, BV: blood vessels.
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therefore 10×MIC concentration was used on the 
wounded rats. Of note, if the peptide B-2Ta is going to be 
developed for clinical application, the haemolysis needs 
to be further decreased. Amino acid substitutions in the 
primary structure of the peptide is a commonly approach 
to balance the net charged and hydrophobicity in B-2Ta, 
which is essential to achieve the best antimicrobial activity 
while minimising red blood cell lysis, and warrant further 
investigations [13].
(Continued )
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Figure 8 (Continued ): (A) CD31 and (B) IL-10 immunohistochemical (IHC) staining of skin wounds on day 9 after inoculation of K. 
p. Sections showed the intensity of protein expression of (a) uninfected control, (b) 108 K. p-infected group, (c) 2×MIC gentamicin-treated 
group and (d) 10×MIC B-2Ta-treated group. 
(Continued )
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Figure 8 (Continued ): (C) CD31, angiogenesis index=average vessel counts per field. (D) The intensity of positive stains was assessed 
by a mean density of the AOI (area of interest). Data are expressed as mean ± SEM of three sections. The arrows represent the endothelial 
CD31 positive blood vessels in graphs of (A). Significance: * P<0.05 vs uninfected group or between indicated groups, # p<0.05 between 
indicated groups.
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In this study, Figure 4 showed a remarkable 
acceleration of wound closure rate in the high-dosage 
of the B-2Ta-treated group in the period of day 9 to day 
13. The apparent outcomes indicate the improvement 
efficiency of B-2Ta in the wound healing process. 
The intrinsic mechanisms might be directly promoting 
the wound healing process. Inflammation is a cellular 
protective response to pathogens, infection or tissue 
damage. In the early stage of wound healing, the primary 
immature granulation tissue is forming with inflammatory 
cells, angioblasts, fibroblasts, collagen fibres and new 
blood vessels, which are essential in the later stage in 
repairing the wound and composing mature granulation 
tissues [14]. The neovascularisation process launches from 
the proliferative phase as early as the third day of creating 
the injuries, involving endothelial cell proliferation and 
vessel formation [15]. The infected wound environment 
commonly has reduced release of angiogenic growth 
factors and inhibited angiogenesis process. We probed 
the CD 31 (pecam-1) on day 4, day 9 and day 13 as the 
indicator to assess the wound angiogenesis capability, 
and we quantified vessel distribution through the tissue 
sections. CD31 is a common signalling molecule 
expressed among the vascular compartment, which is 
known to have diverse roles in vascular biology including 
angiogenesis, platelet function, and thrombosis [16]. 
Previous reports found that the expression of CD31 
is reduced in endothelial cells upon the stimulation of 
tumour necrosis factor (TNF)-alpha [17], and under 
inflammatory conditions, CD31 is downregulated. CD31 
is also viewed as a protective molecule under certain acute 
and chronic inflammatory conditions, such as in collagen-
induced arthritis [18, 19] and pulmonary hyperoxia [20]. 
In uninfected rats, the wounds expressed higher levels 
of CD 31 than all infected rats on day 4 and day 9, until 
the CD 31 expression levels in 10×MIC B-2Ta-treated 
rats became higher than other groups on day 13. This 
phenomenon suggested that the angiogenesis process was 
protected by the treatment of B-2Ta since the infection has 
been controlled in the late healing period. Additionally, 
we assessed the inflammatory levels of wounds by 
employing interleukin (IL)-10 as an indicator. IL-10 
is an anti-inflammatory cytokine produced by various 
of myeloid and lymphoid cells, and the main sources 
are regulatory T cells, dendritic cells and macrophages 
depending on the ligations or stimulation between the 
metrocyte and upstream factors. The upregulation of 
IL-10 is stimulated by TLR4, TRAF3, NF-κBp65/
p50 and ERK kinase modulated cell signalling. As an 
important anti-inflammatory cytokine [21], IL-10 inhibits 
the activity of Th1, Th2 and CD8+ T cells during the 
infection procedures. It restrains the pathogen clearance 
and mediates the immunopathology [22]. During bacterial 
infection, IL-10 down-regulates Th1 by suppressing 
overexpressed immunopathology associated factors, such 
as IFN-γ and TNF-α, and subsequently preventing multiple 
severe immune responses [8, 23]. It also synergistically 
regulates IL-4, IL-5, and IL-13 to alleviate severe fibrosis 
[24]. The uninfected rats expressed minimal IL-10 among 
the four groups, while the K. p-infected control released 
large amounts of IL-10 during the whole experiment 
period, reflecting a serious condition of inflammatory 
substances and factors in the wounds. Although we 
hypothesise that the peptide B-2Ta inhibited or kill the 
bacterial though a membrane disruption mechanism, we 
don’t rule out the possibility that B-2Ta could partially 
exert its function via activating IL-10 signalling to trigger 
immune response locally. In another aspect, time scale 
measurements between the three infected groups indicated 
that the bacterial infection was not improved in the early 
and middle healing stages.
In this study, it was verified that B-2Ta, as an AMP, 
effectively restrained K. p growth through damaging 
the integrity of microorganism structures in the wound 
environment, improved the bacterial infection status 
and accelerated the angiogenesis and granulation tissue 
maturing process. On the cellular level, reduction of IL-
10 demonstrated that B-2Ta could relieve inflammation 
by targeting the bacterial infection. In conclusion, B-2Ta 
promoted angiogenesis and re-epithelialisation in K. 
p-infected rats in a comparable rate with conventional 
antibiotics, which provided evidence and clues for further 
pre-clinical studies of B-2Ta as a novel antimicrobial 
agent.
MATERIALS AND METHODS
Specimen biodata, animals and Klebsiella 
pneumoniae strain
Pelophylax kl. esculentus (n=30) were obtained 
from a commercial source. The frogs were adults and 
settled for three months before secretion harvesting. Skin 
secretions were obtained from the dorsal skin by mild 
transdermal electrical stimulation (4 ms pulse width, 50 
Hz, 5 V) for 30s [25] prior to collected by rinsing with 
distilled deionized water, and then subjected to snap frozen 
with liquid nitrogen, lyophilised and stored at −20°C for 
future work.
Three-month aged male Sprague-Dawley (SD) rats 
were obtained from the Experimental Animal Centre of 
Tianjin Medical University (China). Rats were housed 
in individual plastic cages lined with wood shavings, 
maintained on a 12:12 h dark-light cycle, and fed 
standard laboratory rat chow (2018 Teklad Global 18% 
Protein Rodent Diet; 3.1 kcal/g, Shardlow Teklad, UK) 
and tap water ad libitum, unless otherwise specified. All 
animal experiments were approved by the Animal Care 
Committee of the National Natural Science Foundation 
of China, project 81403394. The present protocol was 
approved by the host institutional animal care committee.
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The Klebsiella pneumoniae (K. pneumoniae or 
K. p) bacteria sample was collected from the wound 
secretion of a diabetic gangrenous (DF) patient in 
the First Affiliated Hospital of Tianjin university of 
Traditional Chinese Medicine. The secretion was cultured 
and adjusted primarily, and the target bacteria group was 
analysed by a Vitek 60 bacterial identification systems 
(Bio-Merieux, France). The K. p group was diluted into 
Phosphate Buffered Saline (PBS) and measured under 550 
nm until 108 CFU/ml were obtained. During the in vivo 
experiments, the rat wound secretions sampled at specific 
time points were cultured in LB medium at 37°C for 18h, 
for assessing the microbial sensitivity.
Molecular cloning and primary structural 
analysis of novel peptide in the skin secretion of 
pelophylax kl. esculentus
The novel peptide B-2Ta was isolated and identified 
from the skin secretion of Pelophylax kl. esculentus by 
using “shotgun” cloning with a degenerate sense primer 
(S1; 5′-GAWYYAYYHRAGCCYAAADATGTTCA-3′) 
(R=A/G; Y=C/T; H=A/T/C; W=A/T; D=G/A/T) and 
a NUP primer (supplied with the kit) as described by 
the manufacturer (Clontech UK) [26]. LCQ-Fleet™ 
electrospray ion-trap mass spectrometer was used to 
confirm the authenticity of the primary structure of the 
novel peptide from the frog skin secretions [26, 27].
Peptide synthesis and secondary structure 
prediction analyses
Once the primary structure was unequivocally 
confirmed through both mass spectrometry fragmentation 
sequencing and molecular cloning strategy, the solid-phase 
Fmoc chemically approach was adopted via Tribute™ 
automated solid-phase peptide synthesiser 4 (Protein 
Technologies, Tucson, AZ, USA) to synthesise the novel 
peptide. After that, the secondary structure prediction 
was performed by using SWISS-MODEL workspace 
and HeliQuest for alpha-helix modelling [3, 28–31]. The 
PyMOL visualisation system established a 3D mimic 
pattern of the short peptide.
Antimicrobial assay
The antimicrobial activity was evaluated by MIC 
assay and MBC assay by using four microorganisms: 
The Gram-positive bacterium, Staphylococcus aureus (S. 
aureus) (NCTC 10788), the Gram-negative bacterium, 
Escherichia coli (E. coli) (NCTC 10418) and the 
Klebsiella pneumoniae (K. p) (collected from the First 
Affiliated Hospital of Tianjin university of Traditional 
Chinese Medicine in project 81403394 of National 
Natural Science Foundation of China), and the yeast, 
Candida albicans (C. albicans) (NCPF 1467). These four 
microorganisms were grown in Mueller-Hinton Broth 
(MHB) (Oxoid, Basingstoke, Hampshire, UK) at 37°C 
until logarithmic phase growth. The optical densities 
(ODs) of culture media were detected at 550 nm to 
assess dilution factors required to achieve inoculation 
concentrations of 1×106 CFU/mL for bacteria or 5 ×105 
CFU/mL for the yeast. Tested peptide concentrations 
were prepared from 512 to 1 mg/L before loaded and 
mixed in a 96-well microtiter plate with culture medium 
for 18h incubation at 37°C. The MICs were determined 
as the lowest concentration of peptide where no growth 
was detectable using an ELISA plate reader (Biolise 
BioTek EL808, Winooski, VT, USA). After which, 10 μL 
of medium from each well was inoculated onto Mueller 
Hinton Agar (MHA) (Oxoid, Basingstoke, Hampshire, 
UK) plates to test the MBC. The MBC value is defined as 
the lowest peptide concentrations from which no colonies 
were grown on the MHA plates.
Haemolysis assay
The haemolysis assay was performed using 
erythrocytes prepared from defibrinated horse blood 
(TCS Biosciences Ltd., Buckingham, UK). Two hundred 
μL of 4% (v/v) suspension of erythrocytes in PBS were 
incubated with peptide gradient prepared in PBS from 
concentration of 512 to 1 mg/L at 37°C for 2 h. Lysis 
of erythrocytes was assessed by measurement of optical 
density at 550 nm using the ELISA plate reader. Negative 
controls and positive controls were PBS alone and PBS 
containing Triton X-100 (Sigma-Aldrich, St. Louis, MO, 
USA), respectively.
Wound induction and Klebsiella pneumonia 
infection
Rats were anesthetised with intraperitoneal injection 
of 3% Nembutal (1 ml/kg), and the dorsal areas were 
depilated using a shaver and soap-suds. A 2-cm wound 
was created on the back of each rat with a dermal 
biopsy punch. The wounds were treated distinctively 
depending on the groups and covered with Tegaderm 
(3M, Minneapolis, MN) to keep them moist and maintain 
consistency. 32 male SD rats were equally divided into 
four groups which were A) uninfected control, B) K. p-
infected control, C) K. p-infected group with 2×MIC 
gentamicin-treatment, D) K. p-infected group with 10× 
MIC B-2Ta treatment. The infection of wounds was 
achieved by inoculation with 20 ul of bacterial suspension 
(CFU 108) and kept one day without treatment for 
proliferation. Alginate powder was dispersed in distilled 
water under vigorous stirring (1500 rpm) for 15 min then 
the solution was left under gentle stirring (100 rpm) for 2 
h. Finally polymer solutions were left motionless for 4 h to 
remove air bubbles [32], B-2Ta peptide loaded gels were 
prepared by mixing in an orbital shaker a precise volume 
of alginate solution to obtain a final peptide concentration 
of 10 x MIC in alginate solution at 5.0% (w/w). Daily 
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parallel treatments were cleaning purulent exudate, cover 
the gel onto the wound and changing the bio-dressing. The 
grouping and treatment procedures are described in Table 
2. During the 14-day period of treatments, the model rats 
were separately fed in isolation to avoid cross infection. 
To observe the wound healing conditions at a molecular 
level and in morphology, each of 8 animals in the same 
group were treated with two schemes: the first 5 rats were 
sampled using a quarter of tissues from different wound 
areas on days 4, 7, 9 and 13, which served for trials of 
morphology, immunohistochemistry and proteomic 
studies; the remaining 3 rats were treated with the same 
method and their dorsal areas were photographed instead 
of cutting the tissues, which was for wound healing 
assessment. After the final treatment on day 14, all the 
animals were euthanised using ethyl carbamate. The 
treatment plan is described in Supplementary Table 1. All 
assessments were blinded to treatment.
Bacterial sampling in wound area for growth 
assessment
During the 14-day treatment, the microbes derived 
from the wound area were cultivated for assessing 
bacterial inhibition abilities. Briefly, exudate samples were 
acquired by fully swabbing moist wounds and diluted into 
10 ml and 100 ml PBS as suspensions. The bacteria were 
daubed onto LB solid media and cultivated overnight to 
check if some colonies will be cultivated on the plate. To 
count live K. p in wound areas, a cylindrical punch with 
a stopping piston was used. Skin samples were taken at 
three sites in the wound at day 1, 4, 9, 13 post infection. 
The biopsies were taken at its deep base and they were 
weighted, homogenised and diluted. The quantity of 
bacteria was determined as CFU / grams (CFU/g).
Sample preparation and scanning electron 
microscopy (SEM)
The morphological changes of bacteria after B-2Ta 
treatment was assessed by SEM which followed the 
protocol published by Chen [33]. Briefly, one ml of K. 
p suspension (108 CFU/mL) was used to mix with 1 ml 
B-2Ta peptide solution to reach a final concentration of 
128 mg/L and cultivated overnight at 37°C. The untreated 
control was prepared in salt-free Lysogeny broth (LB) 
medium only. After the cultivation, the suspensions were 
condensed by centrifugation at 4000 x g for 10 min at 
4°C and then fixed with 2.5% glutaraldehyde at 4°C for 
2 h. After that, the cells were dehydrated by sequential 
treatment with 30, 50, 60, 70, 80, 90 and 100% ethanol for 
10 min each time. Then, a drop of 8 μl dehydrated bacterial 
cell suspension was transfer to a silica plate to air dried 
before mounted. The mounted samples were sputter-coated 
with gold (10s, 50 mA) for observation under a SEM 
(SU8010, Hitachi) at an accelerating voltage of 10 kV.
Wound closure, re-epithelialisation and 
angiogenesis assessment
The dorsal wounds of rats were recorded by 
images when they were created (day 0) and before 
treating at each time. The wound area was measured 
using photo shot software (Scion, Frederick, MD), 
and the percentage of the re-built wound areas was 
calculated by normalised with initial wounding area 
on day 0 by using GraphPad Prism 6.0.1 (San Diego, 
California, USA). The re-epithelialisation condition 
was assessed by a morphological and histological study 
using tissue sections stained with haematoxylin and eosin 
(H&E) [34]. For angiogenesis assessment, the tissue 
slices were immunostained for platelet/endothelial cell 
adhesion molecule-1 (Pecam-1), also known as cluster of 
differentiation (CD) 31 [35].
Immunohistochemical analyses
Paraffin-embedded sections were de-paraffinized 
and placed in water. The endogenous peroxidase activity 
was blocked using 3% H2O2 in methanol [36]. With brief 
rinsing in PBS (PH7.4) (5 min×2), the sections were 
subjected to antigen retrieval in citric acid buffer and 
microwave heating for 3 min × 2, and serum blocking 
in 5% bovine serum albumin (BSA) (Boster, Wuhan, 
China, Ref. AR0004) for 10 min, and incubated in 200 
μg/ml of rabbit polyclonal anti-rat IL-10/CD31 (Boster, 
Wuhan, China, Ref. BA1645-1/BA1201-1/BA2966) in 
0.1% BSA-PBS overnight at 4°C and rinsed in PBS. The 
secondary antibody and Biotin-SP (Boster, Wuhan, China, 
Ref. SA1055) were applied following the manufacturer’s 
instructions. Sections were rinsed in PBS, stained with 
3-Amino-9-ethylcarbazole (AEC), rinsed again and 
counterstained with haematoxylin. The histomorphology 
and gray value of the protein expression were analysed 
through Image-Pro Plus 6.0 software (Media Cybernetics, 
Inc.).
Statistical analysis
Statistical analysis was performed by using ANOVA 
(Bonferroni test) with the SPSS statistical software 18.0 
(SPSS Inc., Chicago, IL, USA). All results are presented 
as mean ± SD, the error bars represent the standard error 
of mean (SEM). Significances were defined when P 
value<0.05.
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